Article

Pharmacological inhibition of CLK2 activates YAP by promoting alternative splicing of…

medRxiv · 2023 · Bulos, M. L.; Grzelak, E. M.; Li-Ma, C.; Chen, E.; Hull, M.; Johnson, K. A.; Bollong, M. J.

Key facts

Title Pharmacological inhibition of CLK2 activates YAP by promoting alternative splicing of AMOTL2
First author Bulos, M. L.; Grzelak, E. M.; Li-Ma, C.; Chen, E.; Hull, M.; Johnson, K. A.; Bollong, M. J.
Journal medRxiv
Published Sep 5, 2023
DOI 10.1101/2023.04.19.537449
Devices mentioned BK110039, DEN000008, K022086, K103302, K810863
Product codes mentioned DBM, JCI, JJH, KIT, NDS, NJT, OOI, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature